Clinical Trial Update: High Dose Oral 4-Aminosalicylic Acid (PASER®) to Control Acute Flares of Mild to Moderate Crohn's Disease [Phase 2]

View source ↗

Summary

A Phase 2 trial of high-dose oral PASER (4-aminosalicylic acid) for controlling acute flares in mild-to-moderate Crohn's disease was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• PASER (4-aminosalicylic acid)

Snippet

Sponsor: Jacobus Pharmaceutical | Conditions: Crohn's Disease | Phase 2 | Status: TERMINATED